APA (7th ed.) Citation

M, P., R, F., B, D. G., M, V., JM, Z., E, G., . . . A, R. (2018). Development of inhibitors of receptor protein tyrosine phosphatase β/ζ (PTPRZ1) as candidates for CNS disorders. European journal of medicinal chemistry, 144, 318. https://doi.org/10.1016/j.ejmech.2017.11.080

Chicago Style (17th ed.) Citation

M, Pastor, et al. "Development of Inhibitors of Receptor Protein Tyrosine Phosphatase β/ζ (PTPRZ1) as Candidates for CNS Disorders." European Journal of Medicinal Chemistry 144 (2018): 318. https://doi.org/10.1016/j.ejmech.2017.11.080.

MLA (9th ed.) Citation

M, Pastor, et al. "Development of Inhibitors of Receptor Protein Tyrosine Phosphatase β/ζ (PTPRZ1) as Candidates for CNS Disorders." European Journal of Medicinal Chemistry, vol. 144, 2018, p. 318, https://doi.org/10.1016/j.ejmech.2017.11.080.